Red wine and component flavonoids inhibit UGT2B17 in vitro

Nutrition Journal

Volumn 11, Issue 1, 2012, Pages

  Jenkinson, Carl ^a   Petroczi, Andrea ^a   Naughton, Declan P ^a  

^a KINGSTON UNIVERSITY   (United Kingdom)

Author keywords

Flavonoids; Glucuronidation; Red wine; Testosterone; UGT2B17

Indexed keywords

ALCOHOL; CAFFEIC ACID; CHLOROGENIC ACID; COUMARIC ACID; FLAVONOID; GALLIC ACID; GLYCOSYLTRANSFERASE; PHENOL; PROTEIN UGT2B17; QUERCETIN; TESTOSTERONE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG GLUCURONIDATION; DRUG INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; PHYSIOLOGY; RED WINE;

CAFFEIC ACIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME INHIBITORS; ETHANOL; FLAVONOIDS; GALLIC ACID; GLUCURONIDES; GLUCURONOSYLTRANSFERASE; HUMANS; MICROSOMES; OSMOLAR CONCENTRATION; PHENOLS; QUERCETIN; RECOMBINANT PROTEINS; TESTOSTERONE; TIME FACTORS; WINE;

EID: 84865833876     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-11-67     Document Type: Article

References (33)

1. Multiresidue determination of 160 pesticides in wines employing mixed-mode dispersive-solid phase extraction and gas chromatography-tandem mass spectrometry. Walorczyk S, Drodyński D, Gnusowski B, Talanta 2011 85 4 1856 1870 10.1016/j.talanta.2011.07.029 21872030
2. Metals in wine-impact on wine quality and health outcomes. Tariba B, Biol Trace Elem Res 2011 144 143 156 10.1007/s12011-011-9052-7 21479541
3. Potential application of dietary polyphenols from red wine to attaining healthy ageing. Magrone T, Jirillo E, Curr Top Med Chem 2011 11 14 1780 1796 10.2174/156802611796235116 21506931
4. Modulation of endogenous antioxidant system by wine polyphenols in human disease. Rodrigo R, Miranda A, Vergara L, Clin Chim Acta 2011 412 5-6 410 424 21130758
5. Suppression of aromatase (estrogen synthetase) by red wine phytochemicals. Eng ET, Williams D, Mandava U, Kirma N, Tekmal RR, Chen S, Breast Cancer Res Treat 2001 67 2 133 146 10.1023/A:1010641102147 11519862 (Pubitemid 32744494)
6. Red wine polyphenols for cancer prevention. He S, Sun C, Pan Y, Int J Molec Sci 2008 9 5 842 853 10.3390/ijms9050842 (Pubitemid 351776200)
7. Meta-analysis of studies of alcohol and breast cancer with consideration of the methodological issues. Key J, Hodgson S, Omar RZ, Jensen TK, Thompson SG, Boobis AR, Davies DS, Elliott P, Cancer Cause Control 2006 17 6 759 770 10.1007/s10552-006-0011-0
8. Turning conventional wisdom upside-down: Low Serum testosterone and high-risk prostate cancer. Morgentaler A, Cancer 2011 117 17 3885 3888 10.1002/cncr.25975 21365620
9. Testosterone in prostate cancer: The Bethesda consensus. Djavan B, Eastham J, Gomella L, Tombal B, Taneja S, Dianat SS, Kazzazi A, Shore N, Abrahamsson PA, Cheetham P, Moul J, Lepor H, Crawford ED, BJU Int 2012 110 344 352 10.1111/j.1464-410X.2011.10719.x 22129242
10. The role of testosterone in the pathogenesis of prostate cancer. Imamoto T, Suzuki H, Yano M, Kawamura K, Kamiya N, Araki K, Komiya A, Nihei N, Naya Y, Ichikawa T, Int J Urol 2008 15 6 472 480 10.1111/j.1442-2042.2008.02074.x 18430151 (Pubitemid 351713199)
11. A prospective cohort study of red wine consumption and risk of prostate cancer. Sutcliffe S, Giovannucci E, Leitzmann MF, Rimm EB, Stampfer MJ, Willett WC, Platz EA, Int J Cancer 2007 120 7 1529 1535 10.1002/ijc.22498 17211860 (Pubitemid 46355389)
12. Red wine consumption and risk of prostate cancer: The California men's health study. Chao C, Haque R, Van Den Eeden SK, Caan BJ, Poon KYT, Quinn VP, Int J Cancer 2010 126 1 171 179 10.1002/ijc.24637 19521962
13. Glucuronidation activity of the UGT2B17 enzyme toward xenobiotics. Turgeon D, Carrier JS, Chouinard S, Bélanger A, Drug Metab Dispos 2003 31 670 676 10.1124/dmd.31.5.670 12695357 (Pubitemid 36444177)
14. Doping and genetic testing: Sex difference in UGT2B15 expression, testosterone glucuronidation activity and urinary testosterone/epitestosterone glucuronide ratio. Ekström L, Gök E, Johansson M, Garle M, Rane A, Schulze JJ, Curr Pharm Pers Med 2012 10 125 131
15. Non-steroidal anti-inflammatory drugs interact with testosterone glucuronidation. Sten T, Finel M, Ask B, Rane A, Ekström L, Steroids 2009 74 971 977 10.1016/j.steroids.2009.07.004 19643121
16. Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP-glucuronosyl transferase 2B17 polymorphism. Jakobsson J, Ekström L, Inotsume N, Garle M, Lorentzon M, Ohlsson C, Roh HK, Carlström K, Rane A, J Clin Endocrinol Metab 2006 91 687 693 16332934 (Pubitemid 43236944)
17. Dietary green and white teas suppress UDP-glucuronosyltransferase UGT2B17 mediated testosterone glucuronidation. Jenkinson C, Petroczi A, Barker J, Naughton DP, Steroids 2012 77 691 695 10.1016/j.steroids.2012.02.023 22429924
18. Wine phenolics. Waterhouse AL, Ann NY Acad Sci 2002 957 21 36 10.1111/j.1749-6632.2002.tb02903.x 12074959 (Pubitemid 34721651)
19. Extraction of testosterone and epitestosterone in human urine using aqueous two-phase systems of ionic liquid and salt. Chiyang H, Shehong L, Huwei L, Kean L, Feng L, J Chromatog A 2005 1082 2 143 149 10.1016/j.chroma.2005.05. 065 (Pubitemid 40852017)
20. Ranking the efficacies of selected red wine phenolic anti-oxidants using reversed-phase HPLC. Seemungal A, Petróczi A, Naughton DP, Eur Food Res Tech 2011 233 5 781 789 10.1007/s00217-011-1571-0
21. Voluntary ethanol consumption in male adolescent hamsters increases testosterone and aggression. Ferris CF, Shtiegman K, King JA, Physiol Behav 1998 63 739 744 10.1016/S0031-9384(97)00533-7 9617993 (Pubitemid 28270530)
22. Acutely administered ethanol participates in testosterone synthesis and increases testosterone in rat brain. Alomary AA, Vallée M, ODell LE, Koob GF, Purdy RH, Fitzgerald RL, Alcohol Clin Exp Res 2003 27 38 43 10.1111/j.1530-0277.2003.tb02718.x 12544003 (Pubitemid 36164246)
23. Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans. Egert S, Wolffram S, Bosy-Westphal A, Boesch-Saadatmandi C, Wagner AE, Frank J, Rimbach G, Mueller MJ, J Nutr 2008 138 9 1615 1621 18716159
24. Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects. Conquer JA, Maiani G, Azzini E, Raguzzini A, Holub BJ, J Nutr 1998 128 593 597 9482769 (Pubitemid 28188358)
25. Strong association between serum levels of leptin and testosterone in men. Behre HM, Simoni M, Nieschlag E, Clin Endocrinol 1997 47 237 240 10.1046/j.1365-2265.1997.2681067.x (Pubitemid 27359905)
26. Plasma levels of caffeic acid and antioxidant status after red wine intake. Simonetti P, Gardana C, Pietta P, J Agric Food Chem 2001 49 5964 5968 10.1021/jf010546k 11743793 (Pubitemid 34062564)
27. Quantitative analysis of 4-ethylphenol and 4-ethylguaiacol in red wine. Pollnitz AP, Pardon KH, Sefton MA, J Chromatogr A 2000 31 101 109 (Pubitemid 30139547)
28. Growth and 4-ethylphenol production by the yeast Pichia guilliermondii in grape juices. Barata A, Nobre A, Correia P, Malfeito-Ferreira M, Loureiro V, Am J Enol Vitic 2006 57 133 138 (Pubitemid 43974646)
29. Bioavailability of testosterone enanthate dependent on genetic variation in the phosphodiesterase 7B but not on the uridine 5-diphospho- glucuronosyltransferase (UGT2B17) gene. Ekstrom L, Schulze JJ, Guillemette C, Belanger A, Rane A, Pharmacogenet Genom 2011 21 325 332 10.1097/FPC. 0b013e328344c5c6
30. A common deletion in the uridine disphosphate glucuronyltransferase (UGT) 2B17 gene is a strong determinant of androgen excretion in healthy pubertal boys. Juul A, Sorensen K, Aksglaese L, Garn I, Rajpert-De Meyts E, Hullstein I, Hemmersbach P, Ottesen AM, J Clin Endocrinol Metab 2009 94 1005 1011 19088161
31. The uridine diphosphate glucuronosyltransferase 2B15 D85Y and 2B17 deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in men. Swanson C, Mellström D, Lorentzon M, Vandenput L, Jakobsson J, Rane A, Karlsson M, Ljunggren O, Smith U, Eriksson A, Bélanger A, Labrie F, Ohlsson C, JCEM 2007 92 4865 4872 17878247
32. Genome-wide copy-number-variation study identified a susceptibility gene, UGT2B17, for osteoporosis. Yang TL, Chen XD, Guo Y, Lei SF, Wang JT, Zhou Q, Pan F, Chen Y, Zhang ZX, Dong SS, Xu XH, Yan H, Liu X, Qiu C, Zhu XZ, Chen T, Li M, Zhang H, Zhang L, Drees BM, Hamilton JJ, Papasian CJ, Recker RR, Song XP, Cheng J, Deng HW, Am J Hum Genet 2008 83 663 674 10.1016/j.ajhg.2008.10.006 18992858
33. Impact of UDP-gluconoryltransferase 2B17 genotype on vorinostat metabolism and clinical outcomes in Asian women with breast cancer. Wong NS, Seah EZH, Wang LZ, Yeo WL, Yap HL, Chuah B, Lim YW, Ang PCS, Tai BC, Lim R, Goh BC, Lee SC, Pharmacogenet Genom 2011 21 11 760 768 10.1097/FPC.0b013e32834a8639